AzTrials
AzTrials

Urinary Bladder, OveractiveNCT00971646

Cohort Study: Perceptual Urge Sensation

An observational study of Urinary Bladder, Overactive and Osteoporosis, run by Maastricht University Medical Center at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Over the past few years it has become clear that our understanding of bladder physiology is inadequate to explain urge incontinence. This has forced us to re-evaluate what we know and do not know about bladder function and dysfunction. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Urinary Bladder, Overactive, Osteoporosis
What is being tested?
Micturition diary, Hospital Anxiety and Depression scale and EuroQol-5D
How many people
160 participants
Where
1 siteNetherlands
Study dates
Jun 2010to 1 Mar 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population consists of two groups: 1: patients with OAB; 2: patients with osteoporosis. The patients with OAB will be reqruited from the outpatient clinic and website designed for patients with overactive bladder symptoms. The patients with osteoporosis will be recruited from an electronic patient database.

Who may be able to join

  • Patients older than 18 years with OAB diagnosed by their urologist using the criteria of more than 8 micturitions on three consecutive days of these three days they keep a micturation diary with a VAS score for urge sensation.
  • Patients should have at least one episode of urge: sudden compelling desire to void which can not be postponed.
  • Well versed in Dutch.
  • Patients older than 18 years with osteoporosis joined into the Fast Guide cohort program.
  • Well versed in Dutch.

Who cannot join

  • Patients with stress-urinary incontinence
  • Presence of post void residual urine > 100cc determined by ultrasound
  • Presence of urinary tract infection, determined by urine sticks. Patients with urinary tract infection will be treated by antibiotics. After resolution of the infection, the patient can re-enter the study if the urine is sterile at that moment.
  • Urinary complaints or urologic history
  • Presence of postvoid residual urine > 100cc determined by ultrasound
  • Presence of urinary tract infection, determined by urine sticks. Patients that present with urinary tract infection will be definitively excluded from participation.

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Maastricht University Medical Centre

    Maastricht, Limburg, 6202 AZ

Other trials in Netherlands

About this study

Over the past few years it has become clear that our understanding of bladder physiology is inadequate to explain urge incontinence. This has forced us to re-evaluate what we know and do not know about bladder function and dysfunction. This has led to the identification and study of novel systems within the bladder that may contribute to abnormal sensations.

The investigators now suspect that the organic changes occurring in the bladder are not the whole story. For one group of patients with pathological urge there is growing evidence suggesting that there may be a strong psychological component. The idea now being put forward is that normal afferent peripheral information is perceived as abnormal and excessive, resulting in an increased desire to go to the bathroom: 'perceptual urge'. It is important to identify this group of patients since it will direct their treatment towards more cognitive approaches. Also, if such a psychological aetiology can be eliminated it would lead to a more focused and effective management of peripheral pathology with surgery or pharmacology.

Being tested
Micturition diary, Hospital Anxiety and Depression scale, EuroQol-5D, Self-consciousness questionnaire
Keywords
overactive bladder, self-consciousness, perceptual urge sensation
Medical subject headings
Urinary Bladder, Overactive, Osteoporosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Micturition diaryOther

    On the micturition diary patients are asked to note every void and drink. With every void they are asked to estimate their bladder volume and grade their degree of desire to void.

  • Hospital Anxiety and Depression scaleOther

    This questionnaire is designed to screen for the presence of a mood disorder.

  • EuroQol-5DOther

    This questionnaire grades the health condition of the subject.

  • Self-consciousness questionnaireOther

    The questions tap cognitive, emotional, and physical appearance aspects of directing their attention to the self.

Study groups in NCT00971646
Study groupRoleWhat they receive
OABPatients with overactive bladder syndrome
Receives: Other: Micturition diary; Other: Hospital Anxiety and Depression scale; Other: EuroQol-5D; Other: Self-consciousness questionnaire
OsteoporosisPatients with osteoporosis
Receives: Other: Micturition diary; Other: Hospital Anxiety and Depression scale; Other: EuroQol-5D; Other: Self-consciousness questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Defining differences in self-consciousness and HADS scores in patients with OAB

    Measured: 1 year

Secondary outcomes (2)
  1. Defining differences between self-consciousness and HADS scores between the two cohorts

    Measured: 1 year

  2. Defining differences in quality of life between the two cohorts

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Sep 2009 (estimated)
  2. Study startJun 2010
  3. Primary completion1 Mar 2017
  4. Study completion1 Mar 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
160 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00971646
Sponsor's protocol ID
09-1234567
Status last verified
Sep 2018
First submitted
3 Sep 2009
Last updated
6 Sep 2018
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Urinary Bladder, Overactive and Osteoporosis, run by Maastricht University Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Defining differences in self-consciousness and HADS scores in patients with OAB (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in